App-Quantinova.ai

Automatic aortic annulus sizing by the heart navigator III software in the planning of transcatheter aortic valve implantation (TAVI)

Elliott Carande - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Gone but not forgotten: a contemporary imaging series of patients with a systemic right ventricle and a lv-pa conduit for native obstruction of the left ventricular outflow tract.

Liam Corbett - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Infective endocarditis

N/A

Severe aortic stenosis management in a tertiary cardiac centre

Norildin Al-Refaie - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

Infective endocarditis: a review of the patient journey at a district general hospital (dgh)

Leanne Eveson - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Infective endocarditis

N/A

The inconsistent choices of inotropic and vasopressors at the front door in patients with ischaemic cardiogenic shock and its impact on in-hospital mortality

Amanda Shabana - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiogenic shock

Norepinephrine topical

Absolute coronary blood flow and microvascular resistance modelling in patients with coronary artery disease

Louise Aubiniere-Robb - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Next generation P2Y12 inhibitors improve survival in ACS: an analysis from the british cardiovascular intervention society database

Fahmida Mannan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Clopidogrel bisulfate

The impact of cardiovascular disease on sex-specific adverse outcomes following intact abdominal aortic aneurysm repair: a systematic review, meta-analysis & meta-regression

Anna Louise Pouncey - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Abdominal aortic aneurysm

N/A

Trans-myocardial extraction of endothelin-1 correlates with increased microvascular resistance following percutaneous coronary intervention

George Abraham - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

endothelin-1

Incidence and one year outcome of periprocedural myocardial infarction following cardiac surgery: are the universal definition and scai criteria fit for purpose?

Jonathan Hinton - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Identifying predictive risk factors for permanent pacemaker implantation up to 30 days post-TAVI

Jiaqi Li - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Valve-in-valve transcatheter aortic valve implantation in trifecta aortic bioprostheses – a single centre experience

Benoy Shah - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Frail patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention have more adverse angiographic features but no difference in rate of complete revascularisation compared to non-frail patients

Benjamin Beska - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Clinical significance of early echocardiography after out-of-hospital cardiac arrest on arrival to a heart attack centre

Ritesh Kanyal - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiogenic shock

N/A

Retrospective analysis of the impact of full vs culprit only revascularisation in octogenarians with multi-vessel coronary artery disease

Nicolas Buttinger - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Multi-vessel disease

N/A

Drug coated balloon only angioplasty for STEMI

Ioannis Merinopoulos - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiogenic shock

N/A

Utility of dobutamine stress echo in predicting cardiac events; a retrospective audit of dse’s at the mater infirmorum hospital, belfast

Patrick Savage - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Dobutamine

Troponin is independently associated with increased short-term mortality in hospitalised patients with COVID-19 infection: a retrospective study in an inner city london hospital

Vijay Shyam-Sundar - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Highly sensitive troponin assay as a single serum test in patients presenting to a rapid access chest pain clinic in non-teaching hospital in the UK

Indra Ramasamy - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

N/A

Routine versus clinically indicated use of chest X-rays in patients presenting with ST-elevation myocardial infarction

Noor Leelo - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Filters

45280 Abstracts